Ardea Biosciences, Inc. (NASDAQ:RDEA) Investor Alert: Lawsuit to Block Merger with AstraZeneca
An investor in NASDAQ:RDEA shares filed a lawsuit in effort to stop the proposed merger between Ardea Biosciences, Inc. and AstraZeneca and NASDAQ:RDEA stockholders should contact the Shareholders Foundation.
View full press release